Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved D
Outcome
OIG enforcement action against Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved D for healthcare fraud.
Details
Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved D — OIG Enforcement (2026)
OIG took enforcement action against Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved D in CA in 2026 involving healthcare fraud violations in the Hospitals / Health Systems sector.
Violation types: Healthcare Fraud
Entity type: Hospital
Penalty type: Criminal
Location: CA
Source: Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved Drug
How Crucible Prevents This
Crucible's compliance monitoring controls for Hospitals / Health Systems would have detected the patterns underlying this violation through automated screening, documentation enforcement, and real-time alert escalation.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works